Published in Women's Health Weekly, October 14th, 2010
GP88 is a glycoprotein that plays a critical role in the development of human cancers, including breast and lung cancer. Overexpression of GP88 has been shown to be associated with cancer cell growth, survival, metastasis, and chemoresistance. The SBIR grant will support the humanization of the neutralizing antibody and ongoing...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly